Global Cancer Pain Market – Industry Trends and Forecast to 2030

Cancer Pain Market Analysis and Size

There is a growing incidence of cancer pain which is estimated to increase the market growth. As per the National Cancer Institute, as of December 2021, about 20-50% cancer patients suffer from pain. With the rising incidence of cancer, the high awareness for the disease along with the associated pain is also rising. These major market players are involved in mergers & acquisitions, collaborations, and various new product launches to boost their market presence.

 Data Bridge Market Research analyses a growth rate in the cancer pain market in the forecast period 2023-2030. The expected CAGR of cancer pain market is tend to be around 5.10% in the mentioned forecast period. The market is valued at USD 6684.2 million in 2022, and it would grow upto USD 9951.2 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cancer Pain Market Scope and Segmentation

Market Definition

Cancer pain is often related with different oncology disorders and is one of the major complications of cancer disorder. The nature of cancer pain primarily depends on the type of cancer, stages and intervention such as targeted therapy and chemotherapy used in the treatment of cancer. The cancer pain initiates because of the enlargement of tumor mass reducing on bones, nerves and other organs.

Cancer Pain Market Dynamics

Drivers

• Growing Elderly Population and Unhealthy Lifestyle

With regards to its growing elderly population, the market is anticipated to grow at a highest speed. The Administration for Community Living shows that the percentage of Americans aged 65 years and older to be increased to 21.6% by 2040 from 16% in 2019. The other main factors causing the market enlargement include the huge adoption of a sedentary lifestyle and increased consumption of saturated and trans fats. About 28% of adults or 1.4 billion people are surviving a sedentary lifestyle which is approximately more than 1 in 4 adults worldwide. Thus, this factor increases the trend of cancer and its associated pain.

• Rising Healthcare Expenditure And Government Support

With the increasing pervasiveness of cancer, the wide awareness for the disease and the associated pain is also rising. This is also causing rising healthcare expenditure for diagnosing and treating cancer-associated pain. As perm the OECD, the initial estimates of healthcare spending for a group of 16 OECD countries jumped to around 9.9% of GDP in 2020. Thus, the increasing healthcare expenditure and government support globally is projected to fuel the market growth.

Opportunities

• Increasing Prevalence of Cancer

According to the Centers for Disease Control and Prevention (CDC), approximately 15.5 million cancer survivors were alive in the U.S. in 2016. That figure is expected to rise to more than 20 million by 2026. As per the National Cancer Institute records, as of December 2021, about 20-50% of cancer patients suffer from pain. Thus, this factor boost the cancer pain market.

• Increasing Options of Drugs

The rising options for multiple drugs increase the market growth. Aspirin-like drugs are widely used for bone pain, and pain caused by inflammation. Many people experience stomach problems such as indigestion and bleeding with this kind of medication. Aspirin is usually avoided; as it is too hard on the stomach if taken regularly. Furthermore, paracetamol is essential in cancer pain control. It is generally well-tolerated; do not affect the stomach and won’t thin the blood. It is advantageous to decrease fever and relieve bone pain and is often used along with opioids. Thus, this factor is ​​​​​​​advantageous to the market growth.

 Restraints/Challenges

• High Cost of Treatment

The increasing expenditure related with medications hamper the market growth. These inhibitors cost high and people in the major developing and underdeveloped countries, cause the under treatment of several patients. This hampers the market growth.

This cancer pain market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cancer pain market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cancer Pain Market Scope

The cancer pain market is segmented on the basis of drug class, indication, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Opioids
• Oxycodone
• Hydrocodone
• NSAIDs
• Ibuprofen
• Naproxen
• Others

Indication

• Lung cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Blood Cancer
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cancer Pain Market Regional Analysis/Insights

The cancer pain market is analyzed and market size insights and trends are provided by drug class, indication, route of administration, end-users and distribution channel as referenced above.

The major countries covered in the cancer pain market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for cancer pain market throughout the forecasted period because of the increasing incidence of cancer diseases, huge presence of major market players and wide availability of sophisticated treatment. Furthermore, Europe is considered a second largest growing regional segment because of the high diagnosis rate and increased healthcare infrastructure

Asia-Pacific dominates the market because of the highly developing healthcare facilities and increase in government initiatives.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Cancer Pain Market Share Analysis

The cancer pain market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cancer pain market

Key players operating in the cancer pain market include:

• Abbvie, Inc (U.S.)
• Novartis AG (Switzerland)
• Teva Pharmaceutical Industries Ltd (Israel)
• Pfizer Inc (U.S.)
• Amneal Pharmaceuticals LLC. (U.S.)
• Aurobindo Pharma (India)
• Johnsons & Johnsons Private limited (U.S.)
• GSK Plc (U.K.)
• Sun Pharmaceutical Industries Ltd (India)
• Cipla Inc. (U.S.)
• Ipsen Pharma (France)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Germany)
• Alembic Pharmaceuticals Limited (India)
• Lupin (India)
• Zydus Group (India)
•  Apotex Inc (Canada)
• Aurobindo Pharma (India)
• Endo Pharmaceuticals plc (Ireland)
• Orexo AB (Sweden
• Mundipharma International (U.K.)
• Hisamitsu Pharmaceutical Co.,Inc. (India)

SKU-52934